Balancing the health benefits and environmental risks of pharmaceuticals: Diclofenac as an example.

Pharmaceuticals are designed to improve human and animal health, but even the most beneficial pharmaceuticals might raise some questions concerning the consequences of exposure to non-target organisms. To illustrate this situation and using diclofenac as a case-study, we analyze global consumption and occurrence data to identify hot spots of consumption without occurrence data, review the scientific literature on the harmful environmental effects to determine whether the observed concentrations in freshwater are of environmental concern, summarize the current pharmaceutical and environmental policies to highlight policy gaps, and suggest a series of research and policy recommendations, which can be summarized as follows: we need to improve the current knowledge on occurrence in freshwaters to properly implement environmental policies (i), diclofenac might pose a risk to non-target organisms in freshwater (ii); the harmful effects that some pharmaceuticals may have on the environment are not always addressed by environmental policies (iii).

[1]  M. Ramesh,et al.  Short and long-term effects of clofibric acid and diclofenac on certain biochemical and ionoregulatory responses in an Indian major carp, Cirrhinus mrigala. , 2013, Chemosphere.

[2]  M. Sillanpää,et al.  Fate of diclofenac in municipal wastewater treatment plant - a review. , 2014, Environment international.

[3]  H. Köhler,et al.  Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part II: cytological effects in liver, kidney, gills and intestine of rainbow trout (Oncorhynchus mykiss). , 2004, Aquatic toxicology.

[4]  D. Barceló,et al.  Development of an extraction and purification method for the determination of multi-class pharmaceuticals and endocrine disruptors in freshwater invertebrates. , 2015, Talanta.

[5]  Lee E. Brown,et al.  Global Synthesis and Critical Evaluation of Pharmaceutical Data Sets Collected from River Systems , 2012, Environmental science & technology.

[6]  Kyungho Choi,et al.  Pharmaceuticals and Personal Care Products in the Environment: What Are the Big Questions? , 2012, Environmental health perspectives.

[7]  R. Triebskorn,et al.  Ultrastructural effects of pharmaceuticals (carbamazepine, clofibric acid, metoprolol, diclofenac) in rainbow trout (Oncorhynchus mykiss) and common carp (Cyprinus carpio) , 2007, Analytical and bioanalytical chemistry.

[8]  H. Köhler,et al.  Acute effects of diclofenac and DMSO to Daphnia magna: immobilisation and hsp70-induction. , 2008, Chemosphere.

[9]  J. Schwaiger,et al.  Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part I: histopathological alterations and bioaccumulation in rainbow trout. , 2004, Aquatic toxicology.

[10]  P. Marsalek,et al.  Effects of Subchronic Exposure of Diclofenac on Growth, Histopathological Changes, and Oxidative Stress in Zebrafish (Danio rerio) , 2014, TheScientificWorldJournal.

[11]  Christoph Ort,et al.  Model-based evaluation of reduction strategies for micropollutants from wastewater treatment plants in complex river networks. , 2009, Environmental science & technology.

[12]  E. Topp,et al.  Structural and functional responses of river biofilm communities to the nonsteroidal anti‐inflammatory diclofenac , 2007, Environmental toxicology and chemistry.

[13]  S. Richardson Water analysis: emerging contaminants and current issues. , 2009, Analytical chemistry.

[14]  Rolf Altenburger,et al.  Identification of a phytotoxic photo-transformation product of diclofenac using effect-directed analysis. , 2010, Environmental pollution.

[15]  Andrew Balmford,et al.  Pollution, Politics, and Vultures , 2013, Science.

[16]  C. Eades,et al.  The effects of diclofenac on the physiology of the green shore crab Carcinus maenas. , 2010, Marine environmental research.

[17]  D. Barceló,et al.  Effects of flow intermittency and pharmaceutical exposure on the structure and metabolism of stream biofilms. , 2015, The Science of the total environment.

[18]  E. Weiner National Recommended Water Quality Criteria , 2000 .

[19]  A. Oikari,et al.  Uptake from water, biotransformation, and biliary excretion of pharmaceuticals by rainbow trout , 2011, Environmental toxicology and chemistry.

[20]  Marlene Ågerstrand,et al.  Improving environmental risk assessment of human pharmaceuticals. , 2015, Environmental science & technology.

[21]  J. Blahova,et al.  The effects of diclofenac on early life stages of common carp (Cyprinus carpio). , 2013, Environmental toxicology and pharmacology.

[22]  A. Kotwani Where are we now: assessing the price, availability and affordability of essential medicines in Delhi as India plans free medicine for all , 2013, BMC Health Services Research.

[23]  C. Laforsch,et al.  Single and combined toxicity of pharmaceuticals at environmentally relevant concentrations in Daphnia magna--a multigenerational study. , 2010, Chemosphere.

[24]  M. Parolini,et al.  An in vitro biomarker approach for the evaluation of the ecotoxicity of non-steroidal anti-inflammatory drugs (NSAIDs). , 2009, Toxicology in vitro : an international journal published in association with BIBRA.

[25]  M. Guida,et al.  Gene expression profiling in zebrafish embryos exposed to diclofenac, an environmental toxicant , 2012, Molecular Biology Reports.

[26]  Masanori Seki,et al.  Acute effects of triclosan, diclofenac and carbamazepine on feeding performance of Japanese medaka fish (Oryzias latipes). , 2010, Chemosphere.

[27]  K. Fent,et al.  Ecotoxicology of human pharmaceuticals. , 2006, Aquatic toxicology.

[28]  W. Sanderson,et al.  The coming acceleration of global population ageing , 2008, Nature.

[29]  J. Sumpter,et al.  Putting pharmaceuticals into the wider context of challenges to fish populations in rivers , 2014, Philosophical Transactions of the Royal Society B: Biological Sciences.

[30]  Daniel J Caldwell,et al.  An integrated approach for prioritizing pharmaceuticals found in the environment for risk assessment, monitoring and advanced research. , 2014, Chemosphere.

[31]  Y. Valcárcel,et al.  Biomarker assessment of toxicity with miniaturised bioassays: diclofenac as a case study , 2011, Ecotoxicology.

[32]  H. Köhler,et al.  Developmental toxicity and stress protein responses in zebrafish embryos after exposure to diclofenac and its solvent, DMSO. , 2004, Chemosphere.

[33]  Rik Oldenkamp,et al.  Do concentrations of ethinylestradiol, estradiol, and diclofenac in European rivers exceed proposed EU environmental quality standards? , 2013, Environmental science & technology.

[34]  S Malato,et al.  Application of time-of-flight mass spectrometry to the analysis of phototransformation products of diclofenac in water under natural sunlight. , 2005, Journal of mass spectrometry : JMS.

[35]  M. Gu,et al.  Analysis of the effects diclofenac has on Japanese medaka (Oryzias latipes) using real-time PCR. , 2007, Chemosphere.

[36]  R. Risebrough Conservation biology: Fatal medicine for vultures , 2004, Nature.

[37]  M. Ramesh,et al.  Ecotoxicological impacts of clofibric acid and diclofenac in common carp (Cyprinus carpio) fingerlings: hematological, biochemical, ionoregulatory and enzymological responses. , 2011, Journal of hazardous materials.

[38]  B. Quinn,et al.  Effects of the pharmaceuticals gemfibrozil and diclofenac on the marine mussel (Mytilus spp.) and their comparison with standardized toxicity tests. , 2011, Marine pollution bulletin.

[39]  A. Pollio,et al.  Erratum to “Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac”: [Ecotoxicol. Environ. Saf. 55 (2003) 359–370] , 2003 .

[40]  L. DiPietro A Silent Spring? , 2017, Journal of physical activity & health.

[41]  Alvine C Mehinto,et al.  Uptake and biological effects of environmentally relevant concentrations of the nonsteroidal anti-inflammatory pharmaceutical diclofenac in rainbow trout (Oncorhynchus mykiss). , 2010, Environmental science & technology.